Denmark· DK-28105504014
Terbutalinsulfat "2care4"
A terbutaline product containing terbutalinsulfat, registered in Denmark by 2care4 ApS. The same ATC class is registered in 9 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Terbutaline is registered in 9 of 19 countries.
Countries holding a registration under ATC R03AC03 (terbutaline), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 4 of them publish a price we can compare per daily dose
Terbutaline · ATC R03AC03
9 / 19 countries
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- TERBUTALINSULFAT
- Manufacturer
- 2care4 ApS
- Country
- Denmark (DK)
- ATC code
- R03AC03
- ATC class
- Terbutaline
- Defined daily dose
- 2 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105504014
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
486 interactions on record for terbutaline.
Graded by severity as the source publishes them — 80 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Terbutaline · interactions on record
486 records
- 80 severe
- 379 moderate
- 27 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under R03AC03
Terbutaline, as other registers publish it.
- FinlandBricanylAktiebolaget Draco
- FinlandBricanylAktiebolaget Draco
- FinlandBricanylAstraZeneca Oy
- FinlandBricanylAktiebolaget Draco
- FinlandBricanylAktiebolaget Draco
- FinlandBricanylAstraZeneca Oy
- FinlandBricanylAstraZeneca Oy
- NetherlandsBricanyl 250 Turbuhaler, inhalatiepoeder 250 microgram/dosisAstraZeneca B.V
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e2eb77f6-11d8-40ea-83aa-c92bb925a594 GET /v1/drugs/e2eb77f6-11d8-40ea-83aa-c92bb925a594?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "inhalationspulver",
"source": "dkma",
"strength": "0,5 mg/dosis",
"auth_role": "DKMA",
"dk_drugid": "28105504014",
"substance": "TERBUTALINSULFAT",
"auth_procedure": "Par-Imp",
"in_medicinpriser": true,
"registration_date_serial": "42046"
}See everything about terbutaline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.